Polyendocrine metabolic ovarian syndrome (PMOS) is one of the most common endocrine conditions affecting hundreds of millions of women globally. The former name polycystic ovary syndrome (PCOS) was inaccurate, underpinning the robust nomenclature change process. This review historically traces renaming efforts up to, i...
H. Teede, Saeede Saadati, Rachel Morman et al.· Fertility and Sterility· 0 citations
Do metabolic and hormonal biomarker profiles in early pregnancy and their longitudinal variations across gestation differ among women at high risk of gestational diabetes mellitus (GDM) with and without polyendocrine metabolic ovarian syndrome (PMOS, formerly polycystic ovary syndrome [PCOS]), and are they associ...
Siriluk Tantanavipas, A. Neven, Simon Alesi et al.· Human Reproduction Open· 0 citations
The rationale for the PCOS-to-PMOS rename is discussed, evidence linking PMOS with adverse pregnancy and offspring outcomes is reviewed, and practical implications for obstetric and gynecologic care are outlined.
M. B. Khomami, K. Hoeger, H. Huddleston et al.· American Journal of Obstetri...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.